RSPO2 abnormal transcripts result from read-through in liver tumours with high ss-catenin activation and CTNNB1 mutations. Bayard Q, Nault JC, Zucman-Rossi J. Gut 2020;69:1152-1153.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bayard Q, Nault JC, Zucman-Rossi J. RSPO2 abnormal transcripts result from read-through in liver tumours with high ss-catenin activation and CTNNB1 mutations. Gut 2020;69:1152-1153.
PMID: 31154392